Literature DB >> 24312838

Large Scale Generation and Characterization of Anti-Human CD34 Monoclonal Antibody in Ascetic Fluid of Balb/c Mice.

Leili Aghebati Maleki1, Jafar Majidi, Behzad Baradaran, Jalal Abdolalizadeh, Tohid Kazemi, Ali Aghebati Maleki, Koushan Sineh Sepehr.   

Abstract

PURPOSE: Monoclonal antibodies or specific antibodies are now an essential tool of biomedical research and are of great commercial and medical value. The purpose of this study was to produce large scale of monoclonal antibody against CD34 in order to diagnostic application in leukemia and purification of human hematopoietic stem/progenitor cells.
METHODS: For large scale production of monoclonal antibody, hybridoma cells that produce monoclonal antibody against human CD34 were injected into the peritoneum of the Balb/c mice which have previously been primed with 0.5 ml Pristane. 5 ml ascitic fluid was harvested from each mouse in two times. Evaluation of mAb titration was assessed by ELISA method. The ascitic fluid was examined for class and subclasses by ELISA mouse mAb isotyping Kit. mAb was purified from ascitic fluid by affinity chromatography on Protein A-Sepharose. Purity of monoclonal antibody was monitored by SDS -PAGE and the purified monoclonal antibody was conjugated with FITC.
RESULTS: Monoclonal antibodies with high specificity and sensitivity against human CD34 by hybridoma technology were prepared. The subclass of antibody was IgG1 and its light chain was kappa.
CONCLUSION: The conjugated monoclonal antibody could be a useful tool for isolation, purification and characterization of human hematopoietic stem cells.

Entities:  

Keywords:  Ascetic fluid; Human CD34; Large Scale generation; Monoclonal antibody

Year:  2013        PMID: 24312838      PMCID: PMC3846064          DOI: 10.5681/apb.2013.035

Source DB:  PubMed          Journal:  Adv Pharm Bull        ISSN: 2228-5881


  21 in total

Review 1.  Hematopoietic stem cells.

Authors:  E Gunsilius; G Gastl; A L Petzer
Journal:  Biomed Pharmacother       Date:  2001-05       Impact factor: 6.529

Review 2.  Immunoaffinity chromatography.

Authors:  Jenny Fitzgerald; Paul Leonard; Elaine Darcy; Richard O'Kennedy
Journal:  Methods Mol Biol       Date:  2011

Review 3.  Critical steps in the production of polyclonal and monoclonal antibodies: evaluation and recommendations.

Authors:  Marlies Leenaars; Coenraad F M Hendriksen
Journal:  ILAR J       Date:  2005

4.  CD34 Antigen: Determination of Specific Sites of Phosphorylation In Vitro and In Vivo.

Authors:  Leesa J Deterding; Jason G Williams; Margaret M Humble; Robert M Petrovich; Sung-Jen Wei; Carol S Trempus; Matthew B Gates; Feng Zhu; Robert C Smart; Raymond W Tennant; Kenneth B Tomer
Journal:  Int J Mass Spectrom       Date:  2011-03-30       Impact factor: 1.986

5.  Optimization of growth and secretion of human monoclonal antibodies by hybridomas cultured in serum-free media.

Authors:  A B Lang; U Schuerch; S J Cryz
Journal:  Hybridoma       Date:  1991-06

Review 6.  Next generation immunotherapeutics--honing the magic bullet.

Authors:  Carrie Enever; Thil Batuwangala; Chris Plummer; Armin Sepp
Journal:  Curr Opin Biotechnol       Date:  2009-08-24       Impact factor: 9.740

Review 7.  CD34: structure, biology, and clinical utility.

Authors:  D S Krause; M J Fackler; C I Civin; W S May
Journal:  Blood       Date:  1996-01-01       Impact factor: 22.113

8.  Production and characterization of murine monoclonal antibodies against Haemophilus parasuis and study of their protective role in mice.

Authors:  M Tadjine; K R Mittal; S Bourdon; M Gottschalk
Journal:  Microbiology       Date:  2004-12       Impact factor: 2.777

9.  Development and characterization of monoclonal antibodies against human epidermal growth factor receptor in Balb/c mice.

Authors:  Behzad Baradaran; Ahmad Zavaran Hosseini; Jafar Majidi; Safar Farajnia; Jaleh Barar; Zohair Hassan Saraf; Jalal Abdolalizadeh; Yadollah Omidi
Journal:  Hum Antibodies       Date:  2009

10.  Development of new versions of anti-human CD34 monoclonal antibodies with potentially reduced immunogenicity.

Authors:  Weizhu Qian; Ling Wang; Bohua Li; Hao Wang; Sheng Hou; Xueyu Hong; Dapeng Zhang; Yajun Guo
Journal:  Biochem Biophys Res Commun       Date:  2008-01-09       Impact factor: 3.575

View more
  9 in total

1.  Large scale generation and characterization of anti-human IgA monoclonal antibody in ascitic fluid of BALB/c mice.

Authors:  Fatemeh Ezzatifar; Jafar Majidi; Behzad Baradaran; Leili Aghebati Maleki; Jalal Abdolalizadeh; Mehdi Yousefi
Journal:  Adv Pharm Bull       Date:  2015-03-05

2.  Production and Purification of a Polyclonal Antibody Against Purified Mouse IgG2b in Rabbits Towards Designing Mouse Monoclonal Isotyping Kits.

Authors:  Sadeq Eivazi; Jafar Majidi; Leili Aghebati Maleki; Jalal Abdolalizadeh; Mehdi Yousefi; Majid Ahmadi; Somayeh Dadashi; Zahra Moradi; Elmira Zolali
Journal:  Adv Pharm Bull       Date:  2015-03-05

3.  Generation and Characterization of Anti-CD34 Monoclonal Antibodies that React with Hematopoietic Stem Cells.

Authors:  Leili Aghebati Maleki; Jafar Majidi; Behzad Baradaran; Aliakbar Movassaghpour; Jalal Abdolalizadeh
Journal:  Cell J       Date:  2014-10-04       Impact factor: 2.479

Review 4.  Overview of Albumin and Its Purification Methods.

Authors:  Ramin Raoufinia; Ali Mota; Neda Keyhanvar; Fatemeh Safari; Sara Shamekhi; Jalal Abdolalizadeh
Journal:  Adv Pharm Bull       Date:  2016-12-22

5.  A unique report: development of super anti-human IgG monoclone with optical density over than 3.

Authors:  Leili Aghebati Maleki; Behzad Baradaran; Jalal Abdolalizadeh; Fatemeh Ezzatifar; Jafar Majidi
Journal:  Adv Pharm Bull       Date:  2013-08-20

6.  Physicochemical Evaluation of Lyophilized Formulation of p-SCN-Bn-DOTA- and p-SCN-Bn-DTPA-rituximab for NHL Radio Immunotherapy.

Authors:  Darinka Gjorgieva Ackova; Katarina Smilkov; Emilija Janevik-Ivanovska
Journal:  Iran J Pharm Res       Date:  2016       Impact factor: 1.696

7.  Production and purification of polyclonal antibody against F(ab')2 fragment of human immunoglobulin G.

Authors:  Hadi Nasiri; Zahra Valedkarimi; Leili Aghebati-Maleki; Jalal Abdolalizadeh; Tohid Kazemi; Mojghan Esparvarinha; Jafar Majidi
Journal:  Vet Res Forum       Date:  2017-12-15       Impact factor: 1.054

8.  A methodological approach for production and purification of polyclonal antibody against dog IgG.

Authors:  Somayeh Sadeghi; Leili Aghebati-Maleki; Samira Nozari; Jafar Majidi
Journal:  Vet Res Forum       Date:  2018-03-15       Impact factor: 1.054

9.  Expression and Purification of a PEDV-Neutralizing Antibody and Its Functional Verification.

Authors:  Wenshu Shi; Haiyang Hao; Mengran Li; Jianqin Niu; Yaning Hu; Xingbo Zhao; Qiuyan Li
Journal:  Viruses       Date:  2021-03-12       Impact factor: 5.048

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.